JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'ro 32 3555'

Search results for: 'ro 32 3555'

A5653 AT7867

Target: Akt|PKA|p70 rsk

Summary: Akt1/2/3 and p70S6K/PKA inhibitor

≥16.9 mg/mL
L1030 DiscoveryProbe™ Ion Channel Compound Library

Summary: A unique collection of 199 ion channel-related compounds for high throughput screening (HTS) and high content screening (HCS).
L1030P DiscoveryProbe™ Ion Channel Compound Library Plus

Summary: A unique collection of 350 ion channel-related compounds for high throughput screening (HTS) and high content screening (HCS).
L1052 DiscoveryProbe™ Clinical & FDA approved Drug Library

Summary: A collection of 2726 clinical & FDA approved drugs supplied as lyophilized powder or pre-dissolved DMSO solutions
A1367 ALK-IN-1

Summary: Anaplastic lymphoma kinase (ALK) inhibitor

≥26.45 mg/mL
A4103 LAQ824 (NVP-LAQ824,Dacinostat)

1 Citation

Summary: HDAC inhibitor,potent and novel

insoluble in H2O; insoluble in EtOH; ≥17.45 mg/mL
B3688 ML347

Target: BMP and Other Activin Receptors

Summary: BMP receptor inhibitor,potent and selective

insoluble in H2O; insoluble in EtOH; ≥5.87 mg/mL
L1021 DiscoveryProbe™ FDA-approved Drug Library

Summary: 2320 approved drugs and API from pharmacopoeia
L1051 DiscoveryProbe™ Human Endogenous Metabolite Compound Library

Summary: A collection of 548 Human Endogenous Metabolite Compound supplied as lyophilized powder or pre-dissolved DMSO solutions
B1518 Erteberel (LY500307)

Target: Estrogen and Related Receptors

Summary: ERβ agonist, potent and selective

insoluble in H2O; ≥14.1 mg/mL